Familial chylomicronemia syndrome: The first case reported in Ecuador

Clin Investig Arterioscler. 2022 Nov-Dec;34(6):326-329. doi: 10.1016/j.arteri.2022.08.002. Epub 2022 Sep 30.
[Article in English, Spanish]

Abstract

Familial chylomicronemia syndrome (FCS) is a genetic entity with autosomal recessive inheritance. Mutations in genes (such as APOC2, APOAV, LMF-1, GPIHBP-1) that code for proteins that regulate the maturation, transport, or polymerization of lipoprotein lipase-1 are the most common causes, but not the only ones. The objective of this study was to report the first documented case in Ecuador. CLINICAL CASE: A 38-year-old man presented with chronic hepatosplenomegaly, thrombocytopenia, pancreatic atrophy, and severe hypertriglyceridemia refractory to treatment. A molecular analysis was performed by next generation sequencing that determined a deficiency of Lipoprotein Lipase OMIM #238600 in homozygosis. Genetic confirmation is necessary in order to establish the etiology of HTGS for an adequate management of this pathology.

Keywords: Chylomicron remnants; Chylomicrons; Hipertrigliceridemia; Hypertriglyceridaemia; Lipid metabolism disorders; Lipoprotein lipase; Lipoproteína lipasa; Pancreatitis; Quilomicrones; Remanentes de quilomicrones; Trastornos del metabolismo de los lípidos.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ecuador
  • Humans
  • Hyperlipoproteinemia Type I* / diagnosis
  • Hyperlipoproteinemia Type I* / genetics
  • Hyperlipoproteinemia Type I* / metabolism
  • Hypertriglyceridemia* / etiology
  • Lipoprotein Lipase / genetics
  • Male

Substances

  • Lipoprotein Lipase

Supplementary concepts

  • Familial hyperchylomicronemia syndrome